No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Advate is a brand of Hematological Drugs, which are used to treat a variety of blood disorders, such as hemophilia A, von Willebrand disease, and other rare bleeding disorders. Advate is a recombinant Factor VIII product, which is a protein that helps the blood to clot. It is used to replace the missing or deficient Factor VIII in patients with hemophilia A. Advate is administered intravenously or subcutaneously, and is available in a variety of formulations, including a lyophilized powder, a liquid concentrate, and a pre-filled syringe.
Advate is a widely used Hematological Drug, and is available in many countries around the world. It is manufactured by Shire, a global biopharmaceutical company, and is marketed in the United States by Baxter International. Other companies that produce Hematological Drugs include Novo Nordisk, CSL Behring, and Grifols. Show Less Read more
